The Manufacturers Life Insurance Company Has $270.64 Million Stake in Stryker Corporation $SYK

The Manufacturers Life Insurance Company lifted its position in shares of Stryker Corporation (NYSE:SYK) by 8.2% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 859,544 shares of the medical technology company’s stock after purchasing an additional 65,333 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Stryker were worth $270,642,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. VanderPol Investments L.L.C. boosted its position in Stryker by 1.4% during the 4th quarter. VanderPol Investments L.L.C. now owns 2,084 shares of the medical technology company’s stock worth $732,000 after acquiring an additional 28 shares during the last quarter. KCM Investment Advisors LLC raised its holdings in shares of Stryker by 1.5% in the fourth quarter. KCM Investment Advisors LLC now owns 1,857 shares of the medical technology company’s stock valued at $653,000 after purchasing an additional 28 shares during the last quarter. Rossby Financial LCC lifted its position in shares of Stryker by 6.6% in the fourth quarter. Rossby Financial LCC now owns 451 shares of the medical technology company’s stock worth $159,000 after purchasing an additional 28 shares in the last quarter. Tcfg Wealth Management LLC grew its position in Stryker by 2.7% in the third quarter. Tcfg Wealth Management LLC now owns 1,091 shares of the medical technology company’s stock valued at $403,000 after purchasing an additional 29 shares in the last quarter. Finally, ICW Investment Advisors LLC grew its position in Stryker by 0.6% in the fourth quarter. ICW Investment Advisors LLC now owns 5,096 shares of the medical technology company’s stock valued at $1,791,000 after purchasing an additional 30 shares in the last quarter. 77.09% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on SYK. UBS Group started coverage on shares of Stryker in a research note on Tuesday, July 28th. They set a “buy” rating and a $400.00 price objective for the company. BMO Capital Markets reaffirmed an “outperform” rating and issued a $317.00 target price on shares of Stryker in a research report on Wednesday. JPMorgan Chase & Co. dropped their target price on Stryker from $400.00 to $350.00 and set an “overweight” rating on the stock in a report on Friday, July 31st. Evercore set a $350.00 price target on Stryker in a research report on Monday, July 6th. Finally, Citigroup decreased their price target on Stryker from $399.00 to $360.00 and set a “buy” rating for the company in a research note on Thursday. Eighteen investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $380.40.

Stryker Stock Down 2.0%

Shares of SYK stock opened at $269.98 on Friday. Stryker Corporation has a 52-week low of $269.64 and a 52-week high of $392.55. The stock has a market cap of $103.56 billion, a price-to-earnings ratio of 27.98, a PEG ratio of 1.72 and a beta of 0.76. The firm’s 50-day moving average is $325.65 and its 200-day moving average is $326.84. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16.

Stryker (NYSE:SYK) last posted its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, topping analysts’ consensus estimates of $3.49 by $0.20. The business had revenue of $6.59 billion during the quarter, compared to analysts’ expectations of $6.58 billion. Stryker had a return on equity of 23.63% and a net margin of 14.43%.Stryker’s quarterly revenue was up 9.4% on a year-over-year basis. During the same quarter last year, the company posted $3.13 earnings per share. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Sell-side analysts predict that Stryker Corporation will post 15.03 EPS for the current year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a dividend of $0.88 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.3%. Stryker’s payout ratio is presently 36.48%.

Insider Buying and Selling

In related news, insider Debra King sold 826 shares of the stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total value of $277,783.80. Following the sale, the insider owned 6,210 shares in the company, valued at approximately $2,088,423. This represents a 11.74% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Ronda Stryker sold 300,000 shares of the firm’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $335.90, for a total value of $100,770,000.00. Following the sale, the director directly owned 2,301,375 shares of the company’s stock, valued at $773,031,862.50. This represents a 11.53% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 351,267 shares of company stock valued at $118,197,701. 4.60% of the stock is owned by insiders.

Stryker Profile

Stryker Corporation is a global medical technology company headquartered in Portage, Michigan. The company develops and manufactures products used by hospitals, physicians and other healthcare providers across a range of medical specialties.

Stryker’s principal businesses include orthopaedics, medical and surgical equipment, and neurovascular products. Its offerings include joint replacement and trauma implants, spinal devices, surgical instruments, operating-room equipment, endoscopy systems, surgical navigation technologies, emergency-care products and devices used to treat neurovascular conditions such as stroke.

Founded in 1941 by Dr.